Table of Content

1 Market Overview of Pet Biopharmaceuticals
1.1 Pet Biopharmaceuticals Market Overview
1.1.1 Pet Biopharmaceuticals Product Scope
1.1.2 Pet Biopharmaceuticals Market Status and Outlook
1.2 Global Pet Biopharmaceuticals Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Pet Biopharmaceuticals Market Size by Region (2024-2034)
1.4 Global Pet Biopharmaceuticals Historic Market Size by Region (2024-2024)
1.5 Global Pet Biopharmaceuticals Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Pet Biopharmaceuticals Market Size (2024-2034)
1.6.1 North America Pet Biopharmaceuticals Market Size (2024-2034)
1.6.2 Europe Pet Biopharmaceuticals Market Size (2024-2034)
1.6.3 Asia-Pacific Pet Biopharmaceuticals Market Size (2024-2034)
1.6.4 Latin America Pet Biopharmaceuticals Market Size (2024-2034)
1.6.5 Middle East & Africa Pet Biopharmaceuticals Market Size (2024-2034)
2 Pet Biopharmaceuticals Market by Type
2.1 Introduction
2.1.1 Antiparasitic
2.1.2 Biological Products
2.1.3 Antibacterial
2.1.4 Others
2.2 Global Pet Biopharmaceuticals Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2024-2024)
2.2.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Pet Biopharmaceuticals Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Pet Biopharmaceuticals Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Pet Biopharmaceuticals Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Pet Biopharmaceuticals Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Pet Biopharmaceuticals Revenue Breakdown by Type (2024-2034)
3 Pet Biopharmaceuticals Market Overview by Application
3.1 Introduction
3.1.1 Prevention
3.1.2 Treatment
3.2 Global Pet Biopharmaceuticals Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2024-2024)
3.2.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Pet Biopharmaceuticals Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Pet Biopharmaceuticals Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Pet Biopharmaceuticals Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Pet Biopharmaceuticals Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Pet Biopharmaceuticals Revenue Breakdown by Application (2024-2034)
4 Pet Biopharmaceuticals Competition Analysis by Players
4.1 Global Pet Biopharmaceuticals Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2022)
4.3 Date of Key Players Enter into Pet Biopharmaceuticals Market
4.4 Global Top Players Pet Biopharmaceuticals Headquarters and Area Served
4.5 Key Players Pet Biopharmaceuticals Product Solution and Service
4.6 Competitive Status
4.6.1 Pet Biopharmaceuticals Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zoetis
5.1.1 Zoetis Profile
5.1.2 Zoetis Main Business
5.1.3 Zoetis Pet Biopharmaceuticals Products, Services and Solutions
5.1.4 Zoetis Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.1.5 Zoetis Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Products, Services and Solutions
5.2.4 Boehringer Ingelheim Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Pet Biopharmaceuticals Products, Services and Solutions
5.3.4 Merck Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.3.5 Elanco Recent Developments
5.4 Elanco
5.4.1 Elanco Profile
5.4.2 Elanco Main Business
5.4.3 Elanco Pet Biopharmaceuticals Products, Services and Solutions
5.4.4 Elanco Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.4.5 Elanco Recent Developments
5.5 Virbac
5.5.1 Virbac Profile
5.5.2 Virbac Main Business
5.5.3 Virbac Pet Biopharmaceuticals Products, Services and Solutions
5.5.4 Virbac Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.5.5 Virbac Recent Developments
5.6 Dechra Veterinary Products
5.6.1 Dechra Veterinary Products Profile
5.6.2 Dechra Veterinary Products Main Business
5.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Products, Services and Solutions
5.6.4 Dechra Veterinary Products Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.6.5 Dechra Veterinary Products Recent Developments
5.7 Ceva
5.7.1 Ceva Profile
5.7.2 Ceva Main Business
5.7.3 Ceva Pet Biopharmaceuticals Products, Services and Solutions
5.7.4 Ceva Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.7.5 Ceva Recent Developments
5.8 Vetoquinol
5.8.1 Vetoquinol Profile
5.8.2 Vetoquinol Main Business
5.8.3 Vetoquinol Pet Biopharmaceuticals Products, Services and Solutions
5.8.4 Vetoquinol Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.8.5 Vetoquinol Recent Developments
5.9 Ouro Fino Saude
5.9.1 Ouro Fino Saude Profile
5.9.2 Ouro Fino Saude Main Business
5.9.3 Ouro Fino Saude Pet Biopharmaceuticals Products, Services and Solutions
5.9.4 Ouro Fino Saude Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.9.5 Ouro Fino Saude Recent Developments
5.10 Norbrook
5.10.1 Norbrook Profile
5.10.2 Norbrook Main Business
5.10.3 Norbrook Pet Biopharmaceuticals Products, Services and Solutions
5.10.4 Norbrook Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.10.5 Norbrook Recent Developments
5.11 Jindun
5.11.1 Jindun Profile
5.11.2 Jindun Main Business
5.11.3 Jindun Pet Biopharmaceuticals Products, Services and Solutions
5.11.4 Jindun Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.11.5 Jindun Recent Developments
5.12 Chopperlvya Animal Health
5.12.1 Chopperlvya Animal Health Profile
5.12.2 Chopperlvya Animal Health Main Business
5.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Products, Services and Solutions
5.12.4 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.12.5 Chopperlvya Animal Health Recent Developments
5.13 CAHIC
5.13.1 CAHIC Profile
5.13.2 CAHIC Main Business
5.13.3 CAHIC Pet Biopharmaceuticals Products, Services and Solutions
5.13.4 CAHIC Pet Biopharmaceuticals Revenue (US$ Million) & (2024-2024)
5.13.5 CAHIC Recent Developments
6 North America
6.1 North America Pet Biopharmaceuticals Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pet Biopharmaceuticals Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pet Biopharmaceuticals Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pet Biopharmaceuticals Market Dynamics
11.1 Pet Biopharmaceuticals Industry Trends
11.2 Pet Biopharmaceuticals Market Drivers
11.3 Pet Biopharmaceuticals Market Challenges
11.4 Pet Biopharmaceuticals Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Pet Biopharmaceuticals Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Pet Biopharmaceuticals Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Pet Biopharmaceuticals Market Size Share by Region (2024-2024)
Table 4. Global Pet Biopharmaceuticals Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Pet Biopharmaceuticals Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Pet Biopharmaceuticals Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Pet Biopharmaceuticals Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Pet Biopharmaceuticals Revenue Market Share by Type (2024-2024)
Table 9. Global Pet Biopharmaceuticals Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Pet Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Table 11. North America Pet Biopharmaceuticals Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Pet Biopharmaceuticals Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Pet Biopharmaceuticals Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Pet Biopharmaceuticals Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Pet Biopharmaceuticals Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Pet Biopharmaceuticals Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Pet Biopharmaceuticals Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Pet Biopharmaceuticals Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Pet Biopharmaceuticals Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Pet Biopharmaceuticals Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Pet Biopharmaceuticals Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Pet Biopharmaceuticals Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Pet Biopharmaceuticals Revenue Market Share by Application (2024-2024)
Table 24. Global Pet Biopharmaceuticals Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Pet Biopharmaceuticals Revenue Market Share by Application (2024-2034)
Table 26. North America Pet Biopharmaceuticals Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Pet Biopharmaceuticals Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Pet Biopharmaceuticals Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Pet Biopharmaceuticals Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Pet Biopharmaceuticals Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Pet Biopharmaceuticals Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Pet Biopharmaceuticals Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Pet Biopharmaceuticals Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Pet Biopharmaceuticals Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Pet Biopharmaceuticals Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Pet Biopharmaceuticals Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Pet Biopharmaceuticals Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2022)
Table 39. Date of Key Players Enter into Pet Biopharmaceuticals Market
Table 40. Global Pet Biopharmaceuticals Key Players Headquarters and Area Served
Table 41. Pet Biopharmaceuticals Product Solution and Service
Table 42. Global Pet Biopharmaceuticals Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Zoetis Basic Information List
Table 45. Zoetis Description and Business Overview
Table 46. Zoetis Pet Biopharmaceuticals Products, Services and Solutions
Table 47. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Zoetis (2024-2024)
Table 48. Zoetis Recent Developments
Table 49. Boehringer Ingelheim Basic Information List
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Pet Biopharmaceuticals Products, Services and Solutions
Table 52. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Boehringer Ingelheim (2024-2024)
Table 53. Boehringer Ingelheim Recent Developments
Table 54. Merck Basic Information List
Table 55. Merck Description and Business Overview
Table 56. Merck Pet Biopharmaceuticals Products, Services and Solutions
Table 57. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Merck (2024-2024)
Table 58. Merck Recent Developments
Table 59. Elanco Basic Information List
Table 60. Elanco Description and Business Overview
Table 61. Elanco Pet Biopharmaceuticals Products, Services and Solutions
Table 62. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Elanco (2024-2024)
Table 63. Elanco Recent Developments
Table 64. Virbac Basic Information List
Table 65. Virbac Description and Business Overview
Table 66. Virbac Pet Biopharmaceuticals Products, Services and Solutions
Table 67. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Virbac (2024-2024)
Table 68. Virbac Recent Developments
Table 69. Dechra Veterinary Products Basic Information List
Table 70. Dechra Veterinary Products Description and Business Overview
Table 71. Dechra Veterinary Products Pet Biopharmaceuticals Products, Services and Solutions
Table 72. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Dechra Veterinary Products (2024-2024)
Table 73. Dechra Veterinary Products Recent Developments
Table 74. Ceva Basic Information List
Table 75. Ceva Description and Business Overview
Table 76. Ceva Pet Biopharmaceuticals Products, Services and Solutions
Table 77. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Ceva (2024-2024)
Table 78. Ceva Recent Developments
Table 79. Vetoquinol Basic Information List
Table 80. Vetoquinol Description and Business Overview
Table 81. Vetoquinol Pet Biopharmaceuticals Products, Services and Solutions
Table 82. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Vetoquinol (2024-2024)
Table 83. Vetoquinol Recent Developments
Table 84. Ouro Fino Saude Basic Information List
Table 85. Ouro Fino Saude Description and Business Overview
Table 86. Ouro Fino Saude Pet Biopharmaceuticals Products, Services and Solutions
Table 87. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Ouro Fino Saude (2024-2024)
Table 88. Ouro Fino Saude Recent Developments
Table 89. Norbrook Basic Information List
Table 90. Norbrook Description and Business Overview
Table 91. Norbrook Pet Biopharmaceuticals Products, Services and Solutions
Table 92. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Norbrook (2024-2024)
Table 93. Norbrook Recent Developments
Table 94. Jindun Basic Information List
Table 95. Jindun Description and Business Overview
Table 96. Jindun Pet Biopharmaceuticals Products, Services and Solutions
Table 97. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Jindun (2024-2024)
Table 98. Jindun Recent Developments
Table 99. Chopperlvya Animal Health Basic Information List
Table 100. Chopperlvya Animal Health Description and Business Overview
Table 101. Chopperlvya Animal Health Pet Biopharmaceuticals Products, Services and Solutions
Table 102. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Chopperlvya Animal Health (2024-2024)
Table 103. Chopperlvya Animal Health Recent Developments
Table 104. CAHIC Basic Information List
Table 105. CAHIC Description and Business Overview
Table 106. CAHIC Pet Biopharmaceuticals Products, Services and Solutions
Table 107. Revenue (US$ Million) in Pet Biopharmaceuticals Business of CAHIC (2024-2024)
Table 108. CAHIC Recent Developments
Table 109. North America Pet Biopharmaceuticals Market Size by Country (2024-2024) & (US$ Million)
Table 110. North America Pet Biopharmaceuticals Market Size by Country (2024-2034) & (US$ Million)
Table 111. Europe Pet Biopharmaceuticals Market Size by Country (2024-2024) & (US$ Million)
Table 112. Europe Pet Biopharmaceuticals Market Size by Country (2024-2034) & (US$ Million)
Table 113. Asia-Pacific Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 114. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2024-2024) & (US$ Million)
Table 115. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2024-2034) & (US$ Million)
Table 116. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2024-2024)
Table 117. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2024-2034)
Table 118. Latin America Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 119. Latin America Pet Biopharmaceuticals Market Size by Country (2024-2024) & (US$ Million)
Table 120. Latin America Pet Biopharmaceuticals Market Size by Country (2024-2034) & (US$ Million)
Table 121. Middle East & Africa Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 122. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2024-2024) & (US$ Million)
Table 123. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2024-2034) & (US$ Million)
Table 124. Pet Biopharmaceuticals Market Trends
Table 125. Pet Biopharmaceuticals Market Drivers
Table 126. Pet Biopharmaceuticals Market Challenges
Table 127. Pet Biopharmaceuticals Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Biopharmaceuticals Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Pet Biopharmaceuticals Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Pet Biopharmaceuticals Market Share by Regions: 2022 VS 2034
Figure 4. Global Pet Biopharmaceuticals Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Pet Biopharmaceuticals Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Pet Biopharmaceuticals Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Pet Biopharmaceuticals Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Pet Biopharmaceuticals Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Pet Biopharmaceuticals Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Antiparasitic
Figure 11. Global Antiparasitic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Biological Products
Figure 13. Global Biological Products Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Antibacterial
Figure 15. Global Antibacterial Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Pet Biopharmaceuticals Market Size Share by Type: 2022 & 2034
Figure 19. North America Pet Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Figure 20. Europe Pet Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Pet Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Pet Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Pet Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Figure 24. Prevention Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Treatment Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Global Pet Biopharmaceuticals Market Size Share by Application: 2022 & 2034
Figure 27. North America Pet Biopharmaceuticals Revenue Market Share by Application (2024-2034)
Figure 28. Europe Pet Biopharmaceuticals Revenue Market Share by Application (2024-2034)
Figure 29. Asia-Pacific Pet Biopharmaceuticals Revenue Market Share by Application (2024-2034)
Figure 30. Latin America Pet Biopharmaceuticals Revenue Market Share by Application (2024-2034)
Figure 31. Middle East and Africa Pet Biopharmaceuticals Revenue Market Share by Application (2024-2034)
Figure 32. Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 33. Global Top 5 and Top 10 Players Pet Biopharmaceuticals Market Share in 2022
Figure 34. North America Pet Biopharmaceuticals Market Share by Country (2024-2034)
Figure 35. United States Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 36. Canada Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 37. Germany Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 38. France Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 39. U.K. Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 40. Italy Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 41. Russia Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 42. Nordic Countries Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 43. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2024-2034)
Figure 44. China Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 45. Japan Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 46. South Korea Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 47. Southeast Asia Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 48. India Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 49. Australia Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 50. Latin America Pet Biopharmaceuticals Market Share by Country (2024-2034)
Figure 51. Mexico Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 52. Brazil Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 53. Middle East & Africa Pet Biopharmaceuticals Market Share by Country (2024-2034)
Figure 54. Turkey Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 56. UAE Pet Biopharmaceuticals Market Size (2024-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report